Published online Sep 26, 2021. doi: 10.4252/wjsc.v13.i9.1293
Peer-review started: February 28, 2021
First decision: April 19, 2021
Revised: April 29, 2021
Accepted: August 13, 2021
Article in press: August 13, 2021
Published online: September 26, 2021
Processing time: 201 Days and 22.2 Hours
Core Tip: Empty nose syndrome is a complex disease, which pathogenesis is associated not only with changes in the architecture of the nasal passages, but also with changes in the receptor status of the nasal mucosa and disorders of perception of external stimuli at the systemic level. Due to the lack of effective convencial protocols for the treatment of this disease, there is a need to find new approaches to restoring the normal structure of the architecture of the nasal passages and return the functionality of the nasal mucosa. In addition, the proposed methods should be minimally invasive, implemented by injection. The advancement of regenerative medicine and biotechnology contributes to the development of new cell-based products in combination with various materials, which in the future will be able to help develop protocols for treatment patients with empty nose syndrome.
